QNCX · Quince Therapeutics, Inc.
$33.75
+1.25 (+3.85%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$35.29M
Shares
1.02M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding QNCX
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Invesco DWA NASDAQ Momentum ETF | — | 5,710 | $268,313 | 0.53% | Long | 2020-01-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 680 | $62,329 | 0.86% | Long | 2021-09-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | — | 391 | $762 | 0.00% | Long | 2022-07-31 | |
| Guggenheim Active Allocation Fund | GUG | 11 | $13 | 0.00% | Long | 2026-05-29 |
Showing 1–4 of 4 positions
Key facts
CIK
1662774
CUSIP
22053A305
13F (30d)
32 filings
28 filers
Visit website
Investor relations